We are live on ! Find out more
PALI icon

Palisade Bio
PALI

8 hedge funds and large institutions have $56.2M invested in Palisade Bio in 2014 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more funds holding

Funds holding: 7 → 8 (+1)

0% more ownership

Funds ownership: 0% → 0% (+0%)

2% less capital invested

Capital invested by funds: $57.1M → $56.2M (-$871K)

49% less call options, than puts

Call options by funds: $351K | Put options by funds: $691K

Holders
8
Holders Change
+1
Holders Change %
+14.29%
% of All Funds
0.21%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
1
Increased
1
Reduced
–
Closed
–
Calls
$351K
Puts
$691K
Net Calls
-$340K
Net Calls Change
-$552K

Top Buyers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
+$3.29M

Top Sellers

Rank Fund Capital Flow
1
MLICM
Metropolitan Life Insurance Company (MetLife)
New York
-$183K
2
UCFA
United Capital Financial Advisors
Texas
-$66K
3
TRCT
Tower Research Capital (TRC)
New York
-$34K
4
Jane Street
Jane Street
New York
-$33K
5
M&T Bank
M&T Bank
New York
-$33K
Name Holding Trade Value Shares
Change 		Change in
Stake
PI
1
Putnam Investments
Massachusetts
$12.1M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$7.7M – – –
ACM
3
Alethea Capital Management
Washington
$5.81M +$6.59M +2 New
BFA
4
BlackRock Fund Advisors
California
$5.33M +$3.29M +1 +100%
FAM
5
Fred Alger Management
New York
$3.71M – – –
BIT
6
BlackRock Institutional Trust
California
$2.22M – – –
State Street
7
State Street
Massachusetts
$2.16M – – –
Northern Trust
8
Northern Trust
Illinois
$2.09M – – –
Geode Capital Management
9
Geode Capital Management
Massachusetts
$1.38M – – –
JPCCM
10
J&P (China) Capital Management
China
$1.28M – – –
CS
11
Credit Suisse
Switzerland
$1.2M – – –
IGIM
12
I.G. Investment Management
Manitoba, Canada
$1.03M – – –
Bank of New York Mellon
13
Bank of New York Mellon
New York
$834K – – –
BCM
14
Bridgeway Capital Management
Texas
$740K – – –
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
$677K – – –
TCIM
16
TIAA CREF Investment Management
New York
$622K – – –
BIM
17
BlackRock Investment Management
Delaware
$549K – – –
California Public Employees Retirement System
18
California Public Employees Retirement System
California
$509K – – –
D.E. Shaw & Co
19
D.E. Shaw & Co
New York
$401K – – –
Mackenzie Financial
20
Mackenzie Financial
Ontario, Canada
$383K – – –
LPL Financial
21
LPL Financial
California
$353K – – –
AQR Capital Management
22
AQR Capital Management
Connecticut
$350K – – –
California State Teachers Retirement System (CalSTRS)
23
California State Teachers Retirement System (CalSTRS)
California
$347K – – –
Morgan Stanley
24
Morgan Stanley
New York
$327K – – –
Fifth Third Bancorp
25
Fifth Third Bancorp
Ohio
$326K – – –
1
2 3 4

PALI Hedge Fund Activity: Q4 2014 in Review

8 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q4 2014, worth a combined $56.2M — down 1.5% from $57.1M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new PALI positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $3.29M. The largest seller was Metropolitan Life Insurance Company (MetLife), cutting an estimated $183K.

  • 8 institutional investors held Palisade Bio (PALI) as of Q4 2014, up from 7 in Q3 2014.
  • Funds reported $56.2M of Palisade Bio stock for Q4 2014, down 1.5% quarter-over-quarter.
  • 1 fund opened new Palisade Bio positions in Q4 2014 and 0 closed out, a net change of +1 holder.
  • The largest Palisade Bio buyer in Q4 2014 was BlackRock Fund Advisors, an estimated $3.29M added.
  • The largest Palisade Bio seller in Q4 2014 was Metropolitan Life Insurance Company (MetLife), an estimated $183K sold.

Based on aggregated 13F filings for Q4 2014.